Department of Chemistry, Miranda House, University of Delhi , Delhi, India.
Laboratory for Translational Chemistry and Drug Discovery, Department of Chemistry, Hansraj College University Enclave, University of Delhi , Delhi, India.
Expert Opin Drug Discov. 2020 Jun;15(6):705-718. doi: 10.1080/17460441.2020.1740203. Epub 2020 Mar 21.
The unique physicochemical properties and chemical diversity of organofluorine compounds have remarkably contributed for their wide utility in the area of pharmaceuticals, materials and agrochemicals. The noteworthy characteristics of fluorine include high electron affinity, lipophilicity and bioavailability, extending the half-life of the drugs. The incorporation of fluorine substituents, particularly trifluoromethyl groups, into organic molecules has led to their high potency against various diseases, including malaria. Hence, organofluorinated molecules offer valuable avenues for the design of new drug candidates against malaria.
In this review, the authors discuss the importance of fluorine substituents present in the chemical compounds, and their potential applications for antimalarial drug discovery.
Fluorinated molecules represent a reliable strategy to develop new antimalarial drugs. Fluorine or fluorinated groups have been identified as a promising precursor, and their presence in approximately twenty-five percent of approved drugs is notable. Selective fluorination of chemical entities has the potential to be applied not only to improve the activity profile against the malaria parasite, but could be extrapolated for favorable pharmacological applications. Hazardous reagents such as HF, F and SF used for fluorination, are not considered as safe, and therefore, this process remains challenging, particularly for the pharmaceutical industry.
有机氟化合物独特的物理化学性质和化学多样性极大地促进了它们在药物、材料和农用化学品领域的广泛应用。氟的显著特点包括高电子亲和力、亲脂性和生物利用度,延长了药物的半衰期。将氟取代基,特别是三氟甲基,引入有机分子中,提高了它们对各种疾病(包括疟疾)的药效。因此,有机氟化合物为设计针对疟疾的新药候选物提供了有价值的途径。
在这篇综述中,作者讨论了化学化合物中氟取代基的重要性及其在抗疟疾药物发现中的潜在应用。
氟化分子是开发新抗疟药物的可靠策略。氟或氟化基团已被确定为有前途的前体,在大约 25%的已批准药物中都存在。化学实体的选择性氟化不仅有可能提高对疟原虫的活性谱,而且可以推断出对有利的药理学应用。用于氟化的 HF、F 和 SF 等危险试剂并不被认为是安全的,因此,这个过程仍然具有挑战性,特别是对于制药行业。